Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 4/8/2025Duality Bio Upsizes IPO Amid Global Market Challenges
  • 4/8/2025Asia-Pacific Vaccine Market Set for Steady Growth Through 2035 Despite...
  • 4/8/2025Tariffs Spark Market Jitters, But China's Innovative Drug Sector Remai...
  • 4/8/2025Beijing Unveils Ambitious Policy Package to Supercharge Biopharma Inno...
  • 4/8/2025Hengrui Grants Merck KGaA Exclusive Rights to SHR7280 in Mainland Chin...
  • 4/8/2025TJ Biopharma, Biogen Enter Partnership to Advance Felzartamab in China
  • 4/8/2025Rigerna Thera Advances siRNA Drug Development with Pre-A Financing​
  • 4/7/2025Boehringer Ingelheim Highlights Long-Term Commitment to China, Focuses...
  • 4/7/2025China Receives 2.6 Million ADR Reports in 2024, Severe Cases Make Up 1...
  • 4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses
  • 4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...
  • 4/5/2025Recent Executive Moves
  • 4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations
  • 4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...
  • 4/5/2025China and WHO Collaborate on Quality Management Training to Boost Vacc...
  • 4/5/2025Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy
  • 4/5/2025Sanofi and Cathay Capital Launch CNY 2B Healthcare Innovation Fund in ...
  • 4/5/2025Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
  • 4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...
  • 4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
  • 4/1/2025Vivace Thera Raises $35M in Series D Financing
  • 4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
  • 4/1/2025China Accelerates Brain Chip Trials After Initial Success
  • 3/31/2025Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib
  • 3/31/2025Bio-Thera and Dr. Reddy's Execute Commercialization Deal for BAT2206 a...
  • 3/31/2025Roche's Ocrevus Receives Chinese Approval for MS
  • 3/31/2025Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...
  • 3/31/2025BMS's Opdivo and Yervoy Combio Approved in China
  • 3/31/2025Vcare PharmaTech Secures Series C+ Financing and Advances Clinical Pip...
  • 3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...
  • Page:15/53 Total number of articles:1568: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group